Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Kosan BioSciences -- KOSN -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (297)	6/24/2003 12:22:41 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 933

No, I didn't get it either. I get the actual form 4 every time one is filed, but don't believe that I've seen 144s in the past?? Don't know that we're in the cheap seats. The degree of SEC-mandated clarity is absurd.

To: keokalani'nui who wrote (297)	6/24/2003 1:00:25 PM
From: quidditch	Read Replies (1) \| Respond to of 933

Wilder, a sale pursuant to a Form 144 is not part of a programmed series of sales, as per mandated, periodic sales intended to avoid any Section 16 or Rule 10b-5 issues. A sale pursuant to Form 144 means that the seller is selling restricted stock within the volume limitations, manner of sale (unsolicited broker's transaction), and holding period requirement (minimum one year--if held for two years, unlimited amounts of stock may be sold if the seller is not an affiliate) and other requirements of the rule (e.g., KOSN is a reporting company under the Exchange Act). A Form 144 is filed in connection with a specific sale, and the Form 4 would reflect the change in his insider's holdings. In any event, in conjunction with the SKI news, doesn't appear to be welcome stuff. quid